Lexaria Bioscience (LEXX) provided an annual letter from CEO Richard Christopher, which read in part, “In 2024, Lexaria made the course ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone shots for people with a rare genetic form of lipodystrophy that leaves patients ...

A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

Leerink Partners analyst David Risinger maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on January 24 and set a price ...

Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...

Weight-loss drugs have been rolled out by the NHS, but many are buying them through social media and online pharmacies ...

"The results give us greater confidence in long-term tirzepatide (Zepbound) market share," Leerink Partners analyst David ...

Enter GetSimpli Oral Tirzepatide, a revolutionary product that promises to transform your approach to weight loss and metabolic health. Unlike traditional weight loss methods that often involve ...

Mounjaro is the brand name for tirzepatide, and research shows that people with overweight and obesity have lost up to 25% of their body weight on this medication. Social media users have latched onto ...

Mounjaro (tirzepatide) is a brand-name drug prescribed to treat type 2 diabetes in adults. Mounjaro comes as a solution inside injection pens that you’ll administer weekly as a subcutaneous ...

Today we've published final guidance for the weight loss medication tirzepatide (mounjaro). It means the phased roll out – set out in our guidance – will begin in 2025. In 2022, the government ...